This is a preview of subscription content, log in via an institution to check access.
Notes
Two of the researchers were employees of Horizon Pharma, Inc., the manufacturer of Duexis, and four of the researchers have served as consultants for Horizon Pharma, Inc.
Reference
Kuan R, et al. Budget Impact Modeling for a Single-Tablet Formulation of Ibuprofen and Famotidine for Prevention of Upper Gastrointestinal Ulcers in Patients With Osteoarthritis and/or Rheumatoid Arthritis. Clinical Therapeutics 35: 321-32, No. 3, Mar 2013. Available from: URL: http://dx.doi.org/10.1016/j.clinthera.2013.02.008
Rights and permissions
About this article
Cite this article
Ibuprofen/famotidine for GI ulcer prevention worth extra cost. PharmacoEcon Outcomes News 675, 8 (2013). https://doi.org/10.1007/s40274-013-0289-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0289-6